The hazards of using vasoactive drugs to augment peripheral and cerebral blood flow.
D000768:Anesthesia, General; D000818:Animals; D001158:Arteries; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D001811:Blood Volume Determination; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output; D002339:Carotid Arteries; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology*; D004285:Dogs; D004809:Ephedrine / Q000494:pharmacology*; D005263:Femoral Artery; D006935:Hypercapnia / Q000503:physiopathology; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000494:pharmacology*; D007668:Kidney / Q000098:blood supply; D008680:Metaraminol / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D010313:Partial Pressure; D010656:Phenylephrine / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects*; D012077:Renal Artery; D013514:Surgical Procedures, Operative; D014294:Trimethaphan / Q000494:pharmacology*; D014554:Urination / Q000187:drug effects; D014680:Veins
D002245:Carbon Dioxide; D010656:Phenylephrine; D014294:Trimethaphan; D008680:Metaraminol; D004809:Ephedrine; D007545:Isoproterenol; D002746:Chlorpromazine; D009638:Norepinephrine